nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP2D6—Temsirolimus—kidney cancer	0.0801	0.136	CbGbCtD
Cinacalcet—CYP3A4—Everolimus—kidney cancer	0.0754	0.128	CbGbCtD
Cinacalcet—CASR—nephron—kidney cancer	0.0617	0.516	CbGeAlD
Cinacalcet—CYP1A2—Pazopanib—kidney cancer	0.0511	0.0865	CbGbCtD
Cinacalcet—CYP3A4—Temsirolimus—kidney cancer	0.0509	0.0863	CbGbCtD
Cinacalcet—CYP2D6—Pazopanib—kidney cancer	0.0421	0.0713	CbGbCtD
Cinacalcet—CYP1A2—Erlotinib—kidney cancer	0.0364	0.0617	CbGbCtD
Cinacalcet—CYP2D6—Erlotinib—kidney cancer	0.03	0.0509	CbGbCtD
Cinacalcet—CYP1A2—Sorafenib—kidney cancer	0.0296	0.0502	CbGbCtD
Cinacalcet—CYP3A4—Pazopanib—kidney cancer	0.0267	0.0453	CbGbCtD
Cinacalcet—CYP2D6—Sorafenib—kidney cancer	0.0244	0.0414	CbGbCtD
Cinacalcet—CYP2D6—Vinblastine—kidney cancer	0.0241	0.0408	CbGbCtD
Cinacalcet—CYP3A4—Erlotinib—kidney cancer	0.0191	0.0323	CbGbCtD
Cinacalcet—CYP3A4—Paclitaxel—kidney cancer	0.0175	0.0296	CbGbCtD
Cinacalcet—CYP3A4—Sorafenib—kidney cancer	0.0155	0.0263	CbGbCtD
Cinacalcet—CYP3A4—Vinblastine—kidney cancer	0.0153	0.026	CbGbCtD
Cinacalcet—CYP3A4—Vincristine—kidney cancer	0.0151	0.0255	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—kidney cancer	0.0148	0.0251	CbGbCtD
Cinacalcet—CASR—nephron tubule—kidney cancer	0.0133	0.111	CbGeAlD
Cinacalcet—CYP3A4—Sunitinib—kidney cancer	0.0126	0.0213	CbGbCtD
Cinacalcet—CASR—renal system—kidney cancer	0.0121	0.101	CbGeAlD
Cinacalcet—CASR—kidney—kidney cancer	0.0117	0.0979	CbGeAlD
Cinacalcet—CYP3A4—Doxorubicin—kidney cancer	0.00942	0.016	CbGbCtD
Cinacalcet—CYP1A2—urine—kidney cancer	0.00614	0.0514	CbGeAlD
Cinacalcet—CYP3A4—urine—kidney cancer	0.00445	0.0372	CbGeAlD
Cinacalcet—CYP2D6—urine—kidney cancer	0.00438	0.0366	CbGeAlD
Cinacalcet—Floctafenine—PTGS1—kidney cancer	0.00157	0.393	CrCbGaD
Cinacalcet—CYP1A2—renal system—kidney cancer	0.0015	0.0126	CbGeAlD
Cinacalcet—CYP3A4—renal system—kidney cancer	0.00109	0.0091	CbGeAlD
Cinacalcet—CYP2D6—renal system—kidney cancer	0.00107	0.00896	CbGeAlD
Cinacalcet—CYP3A4—kidney—kidney cancer	0.00105	0.0088	CbGeAlD
Cinacalcet—CYP2D6—kidney—kidney cancer	0.00103	0.00866	CbGeAlD
Cinacalcet—Floctafenine—PTGS2—kidney cancer	0.000897	0.225	CrCbGaD
Cinacalcet—Triflupromazine—BCHE—kidney cancer	0.000561	0.141	CrCbGaD
Cinacalcet—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000361	0.00153	CcSEcCtD
Cinacalcet—Fatigue—Sorafenib—kidney cancer	0.00036	0.00153	CcSEcCtD
Cinacalcet—Hypertension—Vincristine—kidney cancer	0.00036	0.00152	CcSEcCtD
Cinacalcet—Dyspnoea—Sunitinib—kidney cancer	0.000358	0.00152	CcSEcCtD
Cinacalcet—Constipation—Sorafenib—kidney cancer	0.000357	0.00151	CcSEcCtD
Cinacalcet—Hypersensitivity—Vinblastine—kidney cancer	0.000356	0.00151	CcSEcCtD
Cinacalcet—Myalgia—Vincristine—kidney cancer	0.000355	0.0015	CcSEcCtD
Cinacalcet—Hypersensitivity—Everolimus—kidney cancer	0.000355	0.0015	CcSEcCtD
Cinacalcet—Dyspepsia—Sunitinib—kidney cancer	0.000354	0.0015	CcSEcCtD
Cinacalcet—Decreased appetite—Sunitinib—kidney cancer	0.000349	0.00148	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000347	0.00147	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000347	0.00147	CcSEcCtD
Cinacalcet—Asthenia—Vinblastine—kidney cancer	0.000347	0.00147	CcSEcCtD
Cinacalcet—Fatigue—Sunitinib—kidney cancer	0.000347	0.00147	CcSEcCtD
Cinacalcet—Depression—Capecitabine—kidney cancer	0.000346	0.00147	CcSEcCtD
Cinacalcet—Asthenia—Everolimus—kidney cancer	0.000345	0.00146	CcSEcCtD
Cinacalcet—Cough—Gemcitabine—kidney cancer	0.000345	0.00146	CcSEcCtD
Cinacalcet—Constipation—Sunitinib—kidney cancer	0.000344	0.00146	CcSEcCtD
Cinacalcet—Immune system disorder—Paclitaxel—kidney cancer	0.000343	0.00146	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Sorafenib—kidney cancer	0.000342	0.00145	CcSEcCtD
Cinacalcet—Hypertension—Gemcitabine—kidney cancer	0.000341	0.00145	CcSEcCtD
Cinacalcet—Pruritus—Everolimus—kidney cancer	0.00034	0.00144	CcSEcCtD
Cinacalcet—Arrhythmia—Paclitaxel—kidney cancer	0.00034	0.00144	CcSEcCtD
Cinacalcet—Infection—Vincristine—kidney cancer	0.000338	0.00143	CcSEcCtD
Cinacalcet—Arthralgia—Gemcitabine—kidney cancer	0.000336	0.00143	CcSEcCtD
Cinacalcet—Myalgia—Gemcitabine—kidney cancer	0.000336	0.00143	CcSEcCtD
Cinacalcet—Chest pain—Gemcitabine—kidney cancer	0.000336	0.00143	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000334	0.00142	CcSEcCtD
Cinacalcet—Nervous system disorder—Vincristine—kidney cancer	0.000333	0.00141	CcSEcCtD
Cinacalcet—Asthenia—Erlotinib—kidney cancer	0.000333	0.00141	CcSEcCtD
Cinacalcet—Urticaria—Sorafenib—kidney cancer	0.000332	0.00141	CcSEcCtD
Cinacalcet—Malnutrition—Paclitaxel—kidney cancer	0.000331	0.0014	CcSEcCtD
Cinacalcet—Decreased appetite—Dactinomycin—kidney cancer	0.000331	0.0014	CcSEcCtD
Cinacalcet—Diarrhoea—Vinblastine—kidney cancer	0.00033	0.0014	CcSEcCtD
Cinacalcet—Abdominal pain—Sorafenib—kidney cancer	0.00033	0.0014	CcSEcCtD
Cinacalcet—Body temperature increased—Sorafenib—kidney cancer	0.00033	0.0014	CcSEcCtD
Cinacalcet—Diarrhoea—Everolimus—kidney cancer	0.000329	0.0014	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Sunitinib—kidney cancer	0.000329	0.00139	CcSEcCtD
Cinacalcet—Pruritus—Erlotinib—kidney cancer	0.000328	0.00139	CcSEcCtD
Cinacalcet—Fatigue—Dactinomycin—kidney cancer	0.000328	0.00139	CcSEcCtD
Cinacalcet—Anorexia—Vincristine—kidney cancer	0.000324	0.00137	CcSEcCtD
Cinacalcet—Infection—Gemcitabine—kidney cancer	0.00032	0.00136	CcSEcCtD
Cinacalcet—Dizziness—Vinblastine—kidney cancer	0.000319	0.00135	CcSEcCtD
Cinacalcet—Dizziness—Everolimus—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Muscle spasms—Paclitaxel—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Abdominal pain—Sunitinib—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Body temperature increased—Sunitinib—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Diarrhoea—Erlotinib—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Hypotension—Vincristine—kidney cancer	0.000318	0.00135	CcSEcCtD
Cinacalcet—Nervous system disorder—Gemcitabine—kidney cancer	0.000316	0.00134	CcSEcCtD
Cinacalcet—Skin disorder—Gemcitabine—kidney cancer	0.000313	0.00133	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000311	0.00132	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00031	0.00131	CcSEcCtD
Cinacalcet—Propranolol—CYP1A1—kidney cancer	0.000309	0.0775	CrCbGaD
Cinacalcet—Hypersensitivity—Sorafenib—kidney cancer	0.000308	0.0013	CcSEcCtD
Cinacalcet—Anorexia—Gemcitabine—kidney cancer	0.000307	0.0013	CcSEcCtD
Cinacalcet—Oedema peripheral—Capecitabine—kidney cancer	0.000307	0.0013	CcSEcCtD
Cinacalcet—Vomiting—Vinblastine—kidney cancer	0.000307	0.0013	CcSEcCtD
Cinacalcet—Dizziness—Erlotinib—kidney cancer	0.000307	0.0013	CcSEcCtD
Cinacalcet—Vomiting—Everolimus—kidney cancer	0.000306	0.0013	CcSEcCtD
Cinacalcet—Anaemia—Paclitaxel—kidney cancer	0.000306	0.0013	CcSEcCtD
Cinacalcet—Paraesthesia—Vincristine—kidney cancer	0.000305	0.00129	CcSEcCtD
Cinacalcet—Rash—Everolimus—kidney cancer	0.000303	0.00129	CcSEcCtD
Cinacalcet—Dermatitis—Everolimus—kidney cancer	0.000303	0.00129	CcSEcCtD
Cinacalcet—Headache—Vinblastine—kidney cancer	0.000303	0.00128	CcSEcCtD
Cinacalcet—Angioedema—Paclitaxel—kidney cancer	0.000302	0.00128	CcSEcCtD
Cinacalcet—Headache—Everolimus—kidney cancer	0.000301	0.00128	CcSEcCtD
Cinacalcet—Hypotension—Gemcitabine—kidney cancer	0.000301	0.00128	CcSEcCtD
Cinacalcet—Body temperature increased—Dactinomycin—kidney cancer	0.000301	0.00128	CcSEcCtD
Cinacalcet—Abdominal pain—Dactinomycin—kidney cancer	0.000301	0.00128	CcSEcCtD
Cinacalcet—Asthenia—Sorafenib—kidney cancer	0.0003	0.00127	CcSEcCtD
Cinacalcet—Cardiac failure—Doxorubicin—kidney cancer	0.000298	0.00126	CcSEcCtD
Cinacalcet—Hypersensitivity—Sunitinib—kidney cancer	0.000296	0.00126	CcSEcCtD
Cinacalcet—Decreased appetite—Vincristine—kidney cancer	0.000296	0.00125	CcSEcCtD
Cinacalcet—Pruritus—Sorafenib—kidney cancer	0.000296	0.00125	CcSEcCtD
Cinacalcet—Vomiting—Erlotinib—kidney cancer	0.000295	0.00125	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000294	0.00125	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vincristine—kidney cancer	0.000293	0.00124	CcSEcCtD
Cinacalcet—Fatigue—Vincristine—kidney cancer	0.000293	0.00124	CcSEcCtD
Cinacalcet—Rash—Erlotinib—kidney cancer	0.000293	0.00124	CcSEcCtD
Cinacalcet—Dermatitis—Erlotinib—kidney cancer	0.000292	0.00124	CcSEcCtD
Cinacalcet—Headache—Erlotinib—kidney cancer	0.000291	0.00123	CcSEcCtD
Cinacalcet—Constipation—Vincristine—kidney cancer	0.000291	0.00123	CcSEcCtD
Cinacalcet—Pain in extremity—Doxorubicin—kidney cancer	0.000291	0.00123	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000291	0.00123	CcSEcCtD
Cinacalcet—Paraesthesia—Gemcitabine—kidney cancer	0.00029	0.00123	CcSEcCtD
Cinacalcet—Cough—Paclitaxel—kidney cancer	0.000289	0.00122	CcSEcCtD
Cinacalcet—Asthenia—Sunitinib—kidney cancer	0.000288	0.00122	CcSEcCtD
Cinacalcet—Dyspnoea—Gemcitabine—kidney cancer	0.000288	0.00122	CcSEcCtD
Cinacalcet—Nausea—Vinblastine—kidney cancer	0.000287	0.00122	CcSEcCtD
Cinacalcet—Convulsion—Paclitaxel—kidney cancer	0.000287	0.00122	CcSEcCtD
Cinacalcet—Nausea—Everolimus—kidney cancer	0.000286	0.00121	CcSEcCtD
Cinacalcet—Diarrhoea—Sorafenib—kidney cancer	0.000286	0.00121	CcSEcCtD
Cinacalcet—Hypertension—Paclitaxel—kidney cancer	0.000286	0.00121	CcSEcCtD
Cinacalcet—Pruritus—Sunitinib—kidney cancer	0.000284	0.00121	CcSEcCtD
Cinacalcet—Immune system disorder—Capecitabine—kidney cancer	0.000282	0.00119	CcSEcCtD
Cinacalcet—Arthralgia—Paclitaxel—kidney cancer	0.000282	0.00119	CcSEcCtD
Cinacalcet—Chest pain—Paclitaxel—kidney cancer	0.000282	0.00119	CcSEcCtD
Cinacalcet—Myalgia—Paclitaxel—kidney cancer	0.000282	0.00119	CcSEcCtD
Cinacalcet—Decreased appetite—Gemcitabine—kidney cancer	0.00028	0.00119	CcSEcCtD
Cinacalcet—Hypersensitivity—Dactinomycin—kidney cancer	0.00028	0.00119	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00028	0.00119	CcSEcCtD
Cinacalcet—Arrhythmia—Capecitabine—kidney cancer	0.000279	0.00118	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000278	0.00118	CcSEcCtD
Cinacalcet—Fatigue—Gemcitabine—kidney cancer	0.000278	0.00118	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vincristine—kidney cancer	0.000278	0.00118	CcSEcCtD
Cinacalcet—Dizziness—Sorafenib—kidney cancer	0.000276	0.00117	CcSEcCtD
Cinacalcet—Constipation—Gemcitabine—kidney cancer	0.000276	0.00117	CcSEcCtD
Cinacalcet—Nausea—Erlotinib—kidney cancer	0.000276	0.00117	CcSEcCtD
Cinacalcet—Diarrhoea—Sunitinib—kidney cancer	0.000275	0.00117	CcSEcCtD
Cinacalcet—Asthenia—Dactinomycin—kidney cancer	0.000273	0.00116	CcSEcCtD
Cinacalcet—Malnutrition—Capecitabine—kidney cancer	0.000271	0.00115	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—kidney cancer	0.00027	0.00115	CcSEcCtD
Cinacalcet—Fluoxetine—ABCB1—kidney cancer	0.000269	0.0675	CrCbGaD
Cinacalcet—Body temperature increased—Vincristine—kidney cancer	0.000269	0.00114	CcSEcCtD
Cinacalcet—Abdominal pain—Vincristine—kidney cancer	0.000269	0.00114	CcSEcCtD
Cinacalcet—Infection—Paclitaxel—kidney cancer	0.000268	0.00114	CcSEcCtD
Cinacalcet—Dizziness—Sunitinib—kidney cancer	0.000266	0.00113	CcSEcCtD
Cinacalcet—Vomiting—Sorafenib—kidney cancer	0.000266	0.00113	CcSEcCtD
Cinacalcet—Nervous system disorder—Paclitaxel—kidney cancer	0.000265	0.00112	CcSEcCtD
Cinacalcet—Rash—Sorafenib—kidney cancer	0.000263	0.00112	CcSEcCtD
Cinacalcet—Dermatitis—Sorafenib—kidney cancer	0.000263	0.00112	CcSEcCtD
Cinacalcet—Skin disorder—Paclitaxel—kidney cancer	0.000262	0.00111	CcSEcCtD
Cinacalcet—Headache—Sorafenib—kidney cancer	0.000262	0.00111	CcSEcCtD
Cinacalcet—Muscle spasms—Capecitabine—kidney cancer	0.000261	0.00111	CcSEcCtD
Cinacalcet—Diarrhoea—Dactinomycin—kidney cancer	0.00026	0.0011	CcSEcCtD
Cinacalcet—Anorexia—Paclitaxel—kidney cancer	0.000257	0.00109	CcSEcCtD
Cinacalcet—Vomiting—Sunitinib—kidney cancer	0.000256	0.00108	CcSEcCtD
Cinacalcet—Body temperature increased—Gemcitabine—kidney cancer	0.000255	0.00108	CcSEcCtD
Cinacalcet—Rash—Sunitinib—kidney cancer	0.000253	0.00107	CcSEcCtD
Cinacalcet—Dermatitis—Sunitinib—kidney cancer	0.000253	0.00107	CcSEcCtD
Cinacalcet—Hypotension—Paclitaxel—kidney cancer	0.000252	0.00107	CcSEcCtD
Cinacalcet—Headache—Sunitinib—kidney cancer	0.000252	0.00107	CcSEcCtD
Cinacalcet—Anaemia—Capecitabine—kidney cancer	0.000251	0.00106	CcSEcCtD
Cinacalcet—Hypersensitivity—Vincristine—kidney cancer	0.00025	0.00106	CcSEcCtD
Cinacalcet—Nausea—Sorafenib—kidney cancer	0.000248	0.00105	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000246	0.00104	CcSEcCtD
Cinacalcet—Asthenia—Vincristine—kidney cancer	0.000244	0.00103	CcSEcCtD
Cinacalcet—Paraesthesia—Paclitaxel—kidney cancer	0.000242	0.00103	CcSEcCtD
Cinacalcet—Vomiting—Dactinomycin—kidney cancer	0.000242	0.00103	CcSEcCtD
Cinacalcet—Dyspnoea—Paclitaxel—kidney cancer	0.000241	0.00102	CcSEcCtD
Cinacalcet—Rash—Dactinomycin—kidney cancer	0.00024	0.00102	CcSEcCtD
Cinacalcet—Nausea—Sunitinib—kidney cancer	0.000239	0.00101	CcSEcCtD
Cinacalcet—Dyspepsia—Paclitaxel—kidney cancer	0.000238	0.00101	CcSEcCtD
Cinacalcet—Cough—Capecitabine—kidney cancer	0.000237	0.001	CcSEcCtD
Cinacalcet—Decreased appetite—Paclitaxel—kidney cancer	0.000235	0.000995	CcSEcCtD
Cinacalcet—Hypertension—Capecitabine—kidney cancer	0.000234	0.000994	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000233	0.00099	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000233	0.000988	CcSEcCtD
Cinacalcet—Fatigue—Paclitaxel—kidney cancer	0.000233	0.000987	CcSEcCtD
Cinacalcet—Diarrhoea—Vincristine—kidney cancer	0.000233	0.000986	CcSEcCtD
Cinacalcet—Asthenia—Gemcitabine—kidney cancer	0.000231	0.000981	CcSEcCtD
Cinacalcet—Myalgia—Capecitabine—kidney cancer	0.000231	0.00098	CcSEcCtD
Cinacalcet—Chest pain—Capecitabine—kidney cancer	0.000231	0.00098	CcSEcCtD
Cinacalcet—Arthralgia—Capecitabine—kidney cancer	0.000231	0.00098	CcSEcCtD
Cinacalcet—Constipation—Paclitaxel—kidney cancer	0.000231	0.000979	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00023	0.000973	CcSEcCtD
Cinacalcet—Pruritus—Gemcitabine—kidney cancer	0.000228	0.000967	CcSEcCtD
Cinacalcet—Nausea—Dactinomycin—kidney cancer	0.000226	0.000958	CcSEcCtD
Cinacalcet—Dizziness—Vincristine—kidney cancer	0.000225	0.000953	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000221	0.000936	CcSEcCtD
Cinacalcet—Diarrhoea—Gemcitabine—kidney cancer	0.000221	0.000936	CcSEcCtD
Cinacalcet—Infection—Capecitabine—kidney cancer	0.00022	0.000933	CcSEcCtD
Cinacalcet—Triflupromazine—ABCB1—kidney cancer	0.00022	0.0551	CrCbGaD
Cinacalcet—CASR—Signaling by GPCR—ANXA1—kidney cancer	0.000218	0.00431	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Capecitabine—kidney cancer	0.000217	0.000921	CcSEcCtD
Cinacalcet—Vomiting—Vincristine—kidney cancer	0.000216	0.000916	CcSEcCtD
Cinacalcet—Skin disorder—Capecitabine—kidney cancer	0.000215	0.000913	CcSEcCtD
Cinacalcet—Urticaria—Paclitaxel—kidney cancer	0.000214	0.000909	CcSEcCtD
Cinacalcet—Rash—Vincristine—kidney cancer	0.000214	0.000909	CcSEcCtD
Cinacalcet—Dermatitis—Vincristine—kidney cancer	0.000214	0.000908	CcSEcCtD
Cinacalcet—Body temperature increased—Paclitaxel—kidney cancer	0.000213	0.000905	CcSEcCtD
Cinacalcet—Abdominal pain—Paclitaxel—kidney cancer	0.000213	0.000905	CcSEcCtD
Cinacalcet—Headache—Vincristine—kidney cancer	0.000213	0.000903	CcSEcCtD
Cinacalcet—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000212	0.00419	CbGpPWpGaD
Cinacalcet—Anorexia—Capecitabine—kidney cancer	0.000211	0.000896	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000209	0.00413	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—POMC—kidney cancer	0.000208	0.00411	CbGpPWpGaD
Cinacalcet—Hypotension—Capecitabine—kidney cancer	0.000207	0.000878	CcSEcCtD
Cinacalcet—Vomiting—Gemcitabine—kidney cancer	0.000205	0.000869	CcSEcCtD
Cinacalcet—Rash—Gemcitabine—kidney cancer	0.000203	0.000862	CcSEcCtD
Cinacalcet—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000203	0.00402	CbGpPWpGaD
Cinacalcet—Dermatitis—Gemcitabine—kidney cancer	0.000203	0.000861	CcSEcCtD
Cinacalcet—CASR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000203	0.004	CbGpPWpGaD
Cinacalcet—Headache—Gemcitabine—kidney cancer	0.000202	0.000857	CcSEcCtD
Cinacalcet—Nausea—Vincristine—kidney cancer	0.000202	0.000856	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000202	0.000856	CcSEcCtD
Cinacalcet—Paraesthesia—Capecitabine—kidney cancer	0.000199	0.000844	CcSEcCtD
Cinacalcet—Hypersensitivity—Paclitaxel—kidney cancer	0.000199	0.000843	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—kidney cancer	0.000198	0.00084	CcSEcCtD
Cinacalcet—Dyspnoea—Capecitabine—kidney cancer	0.000198	0.000838	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000197	0.0039	CbGpPWpGaD
Cinacalcet—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000195	0.00385	CbGpPWpGaD
Cinacalcet—Dyspepsia—Capecitabine—kidney cancer	0.000195	0.000827	CcSEcCtD
Cinacalcet—Asthenia—Paclitaxel—kidney cancer	0.000194	0.000821	CcSEcCtD
Cinacalcet—Decreased appetite—Capecitabine—kidney cancer	0.000193	0.000817	CcSEcCtD
Cinacalcet—Nausea—Gemcitabine—kidney cancer	0.000192	0.000812	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.000191	0.00378	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000191	0.000811	CcSEcCtD
Cinacalcet—Fatigue—Capecitabine—kidney cancer	0.000191	0.00081	CcSEcCtD
Cinacalcet—Pruritus—Paclitaxel—kidney cancer	0.000191	0.00081	CcSEcCtD
Cinacalcet—Constipation—Capecitabine—kidney cancer	0.000189	0.000803	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000188	0.00372	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000188	0.00371	CbGpPWpGaD
Cinacalcet—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000188	0.00371	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000185	0.00366	CbGpPWpGaD
Cinacalcet—Diarrhoea—Paclitaxel—kidney cancer	0.000185	0.000783	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—kidney cancer	0.000182	0.00077	CcSEcCtD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000181	0.00358	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Capecitabine—kidney cancer	0.000181	0.000768	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—AKAP13—kidney cancer	0.000181	0.00357	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP2—kidney cancer	0.000181	0.00357	CbGpPWpGaD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.00018	0.00355	CbGpPWpGaD
Cinacalcet—Arrhythmia—Doxorubicin—kidney cancer	0.00018	0.000761	CcSEcCtD
Cinacalcet—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000179	0.00354	CbGpPWpGaD
Cinacalcet—Dizziness—Paclitaxel—kidney cancer	0.000179	0.000757	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000177	0.0035	CbGpPWpGaD
Cinacalcet—Urticaria—Capecitabine—kidney cancer	0.000176	0.000746	CcSEcCtD
Cinacalcet—Abdominal pain—Capecitabine—kidney cancer	0.000175	0.000743	CcSEcCtD
Cinacalcet—Body temperature increased—Capecitabine—kidney cancer	0.000175	0.000743	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—kidney cancer	0.000175	0.000742	CcSEcCtD
Cinacalcet—Vomiting—Paclitaxel—kidney cancer	0.000172	0.000728	CcSEcCtD
Cinacalcet—Rash—Paclitaxel—kidney cancer	0.00017	0.000722	CcSEcCtD
Cinacalcet—Dermatitis—Paclitaxel—kidney cancer	0.00017	0.000721	CcSEcCtD
Cinacalcet—Headache—Paclitaxel—kidney cancer	0.000169	0.000717	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—kidney cancer	0.000168	0.000713	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—GRB7—kidney cancer	0.000165	0.00327	CbGpPWpGaD
Cinacalcet—Propranolol—ABCB1—kidney cancer	0.000164	0.0412	CrCbGaD
Cinacalcet—Hypersensitivity—Capecitabine—kidney cancer	0.000163	0.000692	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—kidney cancer	0.000162	0.000686	CcSEcCtD
Cinacalcet—Nausea—Paclitaxel—kidney cancer	0.00016	0.00068	CcSEcCtD
Cinacalcet—Asthenia—Capecitabine—kidney cancer	0.000159	0.000674	CcSEcCtD
Cinacalcet—Pruritus—Capecitabine—kidney cancer	0.000157	0.000665	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000156	0.00308	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ITPR2—kidney cancer	0.000154	0.00304	CbGpPWpGaD
Cinacalcet—Cough—Doxorubicin—kidney cancer	0.000153	0.000648	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—kidney cancer	0.000152	0.000643	CcSEcCtD
Cinacalcet—Diarrhoea—Capecitabine—kidney cancer	0.000152	0.000643	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—kidney cancer	0.000151	0.000641	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.00015	0.00297	CbGpPWpGaD
Cinacalcet—Myalgia—Doxorubicin—kidney cancer	0.000149	0.000632	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—kidney cancer	0.000149	0.000632	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—kidney cancer	0.000149	0.000632	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000148	0.000627	CcSEcCtD
Cinacalcet—Dizziness—Capecitabine—kidney cancer	0.000147	0.000621	CcSEcCtD
Cinacalcet—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000146	0.00287	CbGpPWpGaD
Cinacalcet—Infection—Doxorubicin—kidney cancer	0.000142	0.000602	CcSEcCtD
Cinacalcet—Vomiting—Capecitabine—kidney cancer	0.000141	0.000597	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—kidney cancer	0.00014	0.000594	CcSEcCtD
Cinacalcet—Rash—Capecitabine—kidney cancer	0.00014	0.000592	CcSEcCtD
Cinacalcet—Dermatitis—Capecitabine—kidney cancer	0.00014	0.000592	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CTNNA1—kidney cancer	0.000139	0.00275	CbGpPWpGaD
Cinacalcet—Headache—Capecitabine—kidney cancer	0.000139	0.000589	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—kidney cancer	0.000139	0.000588	CcSEcCtD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000139	0.00274	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EIF4EBP1—kidney cancer	0.000139	0.00274	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HSPB1—kidney cancer	0.000139	0.00274	CbGpPWpGaD
Cinacalcet—Anorexia—Doxorubicin—kidney cancer	0.000136	0.000577	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—kidney cancer	0.000133	0.000566	CcSEcCtD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000132	0.00261	CbGpPWpGaD
Cinacalcet—Nausea—Capecitabine—kidney cancer	0.000132	0.000558	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00013	0.000552	CcSEcCtD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.00013	0.00256	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.00013	0.00256	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	0.00013	0.00256	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TSC1—kidney cancer	0.000129	0.00255	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PSMD7—kidney cancer	0.000129	0.00255	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ANXA1—kidney cancer	0.000129	0.00255	CbGpPWpGaD
Cinacalcet—Paraesthesia—Doxorubicin—kidney cancer	0.000128	0.000544	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	0.000128	0.00253	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	0.000127	0.00252	CbGpPWpGaD
Cinacalcet—Dyspnoea—Doxorubicin—kidney cancer	0.000127	0.00054	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—kidney cancer	0.000126	0.000533	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—FLT1—kidney cancer	0.000125	0.00246	CbGpPWpGaD
Cinacalcet—Decreased appetite—Doxorubicin—kidney cancer	0.000124	0.000526	CcSEcCtD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000124	0.00245	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000123	0.000523	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—kidney cancer	0.000123	0.000522	CcSEcCtD
Cinacalcet—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000122	0.00242	CbGpPWpGaD
Cinacalcet—Constipation—Doxorubicin—kidney cancer	0.000122	0.000518	CcSEcCtD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000121	0.0024	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—POMC—kidney cancer	0.000118	0.00232	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000117	0.000495	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—JUNB—kidney cancer	0.000116	0.00228	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PAK1—kidney cancer	0.000116	0.00228	CbGpPWpGaD
Cinacalcet—Urticaria—Doxorubicin—kidney cancer	0.000113	0.000481	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—kidney cancer	0.000113	0.000479	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—kidney cancer	0.000113	0.000479	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—POMC—kidney cancer	0.000107	0.00211	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Doxorubicin—kidney cancer	0.000105	0.000446	CcSEcCtD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000105	0.00207	CbGpPWpGaD
Cinacalcet—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000104	0.00205	CbGpPWpGaD
Cinacalcet—Asthenia—Doxorubicin—kidney cancer	0.000102	0.000435	CcSEcCtD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000102	0.00201	CbGpPWpGaD
Cinacalcet—Pruritus—Doxorubicin—kidney cancer	0.000101	0.000428	CcSEcCtD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.0001	0.00198	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.0001	0.00198	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	9.83e-05	0.00194	CbGpPWpGaD
Cinacalcet—Diarrhoea—Doxorubicin—kidney cancer	9.77e-05	0.000414	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—IGF2—kidney cancer	9.46e-05	0.00187	CbGpPWpGaD
Cinacalcet—Dizziness—Doxorubicin—kidney cancer	9.44e-05	0.0004	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CDKN2B—kidney cancer	9.42e-05	0.00186	CbGpPWpGaD
Cinacalcet—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.24e-05	0.00182	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF1R—kidney cancer	9.14e-05	0.00181	CbGpPWpGaD
Cinacalcet—Vomiting—Doxorubicin—kidney cancer	9.08e-05	0.000385	CcSEcCtD
Cinacalcet—Rash—Doxorubicin—kidney cancer	9.01e-05	0.000382	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—kidney cancer	9e-05	0.000381	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—kidney cancer	8.95e-05	0.000379	CcSEcCtD
Cinacalcet—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	8.87e-05	0.00175	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTT1—kidney cancer	8.84e-05	0.00175	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—RAF1—kidney cancer	8.81e-05	0.00174	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—kidney cancer	8.7e-05	0.00172	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.51e-05	0.00168	CbGpPWpGaD
Cinacalcet—Nausea—Doxorubicin—kidney cancer	8.48e-05	0.00036	CcSEcCtD
Cinacalcet—CYP2D6—Biological oxidations—PTGS1—kidney cancer	8.28e-05	0.00164	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	8.15e-05	0.00161	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.1e-05	0.0016	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.99e-05	0.00158	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	7.98e-05	0.00158	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	7.95e-05	0.00157	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—kidney cancer	7.9e-05	0.00156	CbGpPWpGaD
Cinacalcet—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.83e-05	0.00155	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	7.72e-05	0.00153	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HIF1A—kidney cancer	7.53e-05	0.00149	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TSC2—kidney cancer	7.51e-05	0.00148	CbGpPWpGaD
Cinacalcet—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.49e-05	0.00148	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTT1—kidney cancer	7.49e-05	0.00148	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	7.31e-05	0.00144	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	7.31e-05	0.00144	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	7.22e-05	0.00143	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KDR—kidney cancer	7.2e-05	0.00142	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	7.16e-05	0.00141	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—PTGS1—kidney cancer	7.01e-05	0.00139	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	6.96e-05	0.00138	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APC—kidney cancer	6.63e-05	0.00131	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KIT—kidney cancer	6.63e-05	0.00131	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.57e-05	0.0013	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK3—kidney cancer	6.35e-05	0.00125	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.34e-05	0.00125	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—POMC—kidney cancer	6.31e-05	0.00125	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BRAF—kidney cancer	6.23e-05	0.00123	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.19e-05	0.00122	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTP1—kidney cancer	6.12e-05	0.00121	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	6.08e-05	0.0012	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK1—kidney cancer	6.04e-05	0.00119	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	6.04e-05	0.00119	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.04e-05	0.00119	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.78e-05	0.00114	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—kidney cancer	5.77e-05	0.00114	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—kidney cancer	5.71e-05	0.00113	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—GSTM1—kidney cancer	5.63e-05	0.00111	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	5.6e-05	0.00111	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	5.55e-05	0.0011	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	5.47e-05	0.00108	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.41e-05	0.00107	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	5.34e-05	0.00105	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	5.26e-05	0.00104	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—kidney cancer	5.24e-05	0.00104	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RAF1—kidney cancer	5.2e-05	0.00103	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTP1—kidney cancer	5.19e-05	0.00102	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RELA—kidney cancer	5.18e-05	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	5.17e-05	0.00102	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB2—kidney cancer	5.15e-05	0.00102	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	5.12e-05	0.00101	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MTOR—kidney cancer	5.08e-05	0.001	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.9e-05	0.000967	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1B—kidney cancer	4.77e-05	0.000942	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—GSTM1—kidney cancer	4.77e-05	0.000942	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	4.7e-05	0.000929	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACY1—kidney cancer	4.69e-05	0.000927	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—kidney cancer	4.67e-05	0.000922	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—kidney cancer	4.55e-05	0.000899	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—JUN—kidney cancer	4.54e-05	0.000897	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	4.52e-05	0.000893	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—kidney cancer	4.5e-05	0.00089	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	4.46e-05	0.000881	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—kidney cancer	4.39e-05	0.000867	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4e-05	0.000791	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PDHB—kidney cancer	3.99e-05	0.000788	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—POMC—kidney cancer	3.98e-05	0.000786	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACY1—kidney cancer	3.98e-05	0.000785	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—kidney cancer	3.97e-05	0.000783	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.95e-05	0.00078	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CCBL1—kidney cancer	3.75e-05	0.000741	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK3—kidney cancer	3.75e-05	0.000741	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.68e-05	0.000727	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—kidney cancer	3.65e-05	0.000721	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.63e-05	0.000717	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK1—kidney cancer	3.57e-05	0.000705	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.49e-05	0.000689	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.44e-05	0.00068	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.39e-05	0.00067	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PDHB—kidney cancer	3.38e-05	0.000668	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—kidney cancer	3.37e-05	0.000666	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—POMC—kidney cancer	3.37e-05	0.000666	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.25e-05	0.000643	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPAT—kidney cancer	3.25e-05	0.000643	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CCBL1—kidney cancer	3.18e-05	0.000628	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—kidney cancer	3.1e-05	0.000612	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACY1—kidney cancer	3.07e-05	0.000606	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—APRT—kidney cancer	3.02e-05	0.000597	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FH—kidney cancer	3.02e-05	0.000597	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—kidney cancer	3e-05	0.000592	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.87e-05	0.000568	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPC3—kidney cancer	2.84e-05	0.000562	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA2—kidney cancer	2.77e-05	0.000546	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPAT—kidney cancer	2.76e-05	0.000544	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.76e-05	0.000544	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.72e-05	0.000537	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALAD—kidney cancer	2.7e-05	0.000532	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.69e-05	0.000532	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.63e-05	0.00052	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PDHB—kidney cancer	2.61e-05	0.000515	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—POMC—kidney cancer	2.6e-05	0.000514	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.57e-05	0.000508	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FH—kidney cancer	2.56e-05	0.000506	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—APRT—kidney cancer	2.56e-05	0.000506	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.5e-05	0.000495	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PGK1—kidney cancer	2.47e-05	0.000487	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.47e-05	0.000487	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CCBL1—kidney cancer	2.45e-05	0.000485	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LDHB—kidney cancer	2.42e-05	0.000478	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPC3—kidney cancer	2.41e-05	0.000476	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA2—kidney cancer	2.34e-05	0.000463	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALAD—kidney cancer	2.28e-05	0.000451	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.23e-05	0.00044	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.18e-05	0.00043	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.13e-05	0.00042	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPAT—kidney cancer	2.13e-05	0.00042	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CA9—kidney cancer	2.1e-05	0.000414	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PGK1—kidney cancer	2.09e-05	0.000413	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.09e-05	0.000413	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LDHB—kidney cancer	2.05e-05	0.000405	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—APRT—kidney cancer	1.98e-05	0.000391	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FH—kidney cancer	1.98e-05	0.000391	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPC3—kidney cancer	1.86e-05	0.000367	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA2—kidney cancer	1.81e-05	0.000357	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CRABP1—kidney cancer	1.78e-05	0.000352	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CA9—kidney cancer	1.78e-05	0.000351	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALAD—kidney cancer	1.76e-05	0.000348	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.74e-05	0.000343	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.72e-05	0.00034	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.68e-05	0.000332	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ITPR2—kidney cancer	1.66e-05	0.000327	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PGK1—kidney cancer	1.61e-05	0.000318	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.61e-05	0.000318	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LDHB—kidney cancer	1.58e-05	0.000312	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACHE—kidney cancer	1.51e-05	0.000298	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—kidney cancer	1.51e-05	0.000298	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CRABP1—kidney cancer	1.51e-05	0.000298	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SCARB1—kidney cancer	1.43e-05	0.000283	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS1—kidney cancer	1.42e-05	0.00028	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ITPR2—kidney cancer	1.4e-05	0.000277	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PSMD7—kidney cancer	1.39e-05	0.000274	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CA9—kidney cancer	1.37e-05	0.000271	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—BCHE—kidney cancer	1.32e-05	0.00026	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.3e-05	0.000257	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.29e-05	0.000256	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—kidney cancer	1.28e-05	0.000253	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACHE—kidney cancer	1.28e-05	0.000253	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.26e-05	0.000248	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SCARB1—kidney cancer	1.21e-05	0.000239	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS1—kidney cancer	1.2e-05	0.000237	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PSMD7—kidney cancer	1.18e-05	0.000232	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CRABP1—kidney cancer	1.17e-05	0.00023	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—BCHE—kidney cancer	1.12e-05	0.00022	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.1e-05	0.000218	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ITPR2—kidney cancer	1.08e-05	0.000214	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.06e-05	0.00021	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—kidney cancer	1.05e-05	0.000207	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.03e-05	0.000204	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCB1—kidney cancer	9.91e-06	0.000196	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—kidney cancer	9.88e-06	0.000195	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACHE—kidney cancer	9.88e-06	0.000195	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—kidney cancer	9.62e-06	0.00019	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SCARB1—kidney cancer	9.35e-06	0.000185	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS1—kidney cancer	9.26e-06	0.000183	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.12e-06	0.00018	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PSMD7—kidney cancer	9.08e-06	0.000179	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9e-06	0.000178	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—kidney cancer	8.87e-06	0.000175	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—BCHE—kidney cancer	8.61e-06	0.00017	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.5e-06	0.000168	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCB1—kidney cancer	8.4e-06	0.000166	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.21e-06	0.000162	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—kidney cancer	8.15e-06	0.000161	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—kidney cancer	7.73e-06	0.000153	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—kidney cancer	6.85e-06	0.000135	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—POMC—kidney cancer	6.8e-06	0.000134	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCB1—kidney cancer	6.48e-06	0.000128	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.35e-06	0.000125	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—kidney cancer	6.29e-06	0.000124	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.97e-06	0.000118	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—POMC—kidney cancer	5.76e-06	0.000114	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—kidney cancer	5.43e-06	0.000107	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—kidney cancer	4.73e-06	9.35e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—kidney cancer	4.6e-06	9.08e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—POMC—kidney cancer	4.45e-06	8.79e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—kidney cancer	4.01e-06	7.92e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—kidney cancer	3.55e-06	7.01e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.34e-06	6.59e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—kidney cancer	3.09e-06	6.11e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.83e-06	5.59e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.18e-06	4.31e-05	CbGpPWpGaD
